Abstract
The determination of plasma catecholamine levels is commonly used as a measure of the sympathetic nervous system’s response to stress and is highly important for diagnosis, therapy, and prognosis of cardiovascular diseases, catecholamine-secreting tumors arising from the chromaffin cells of the sympathoadrenal system, and affective disorders. Diseases in which catecholamines are significantly elevated include pheochromocytoma, Parkinson’s disease, Alzheimer’s disease, neuroblastoma, ganglioneuroblastoma, von Hippel–Lindau disease, baroreflex failure, chemodectina (nonchromaffin paraganglioma), and multiple endocrine neoplasia. Plasma norepinephrine levels provide a guide to prognosis in patients with stable, chronic, and congestive heart diseases. The method described here for the determination of plasma catecholamines is based on the principle that plasma catecholamines are selectively adsorbed on acid-washed alumina at pH 8.7 and then eluted at a pH between 1.0 and 2.0. Upon injection, catecholamines in elutes were separated by a reversed phase C-18 column. After separation, the catecholamines present within the mobile phase enter the electrochemical detector. Electrochemical detection occurs because electroactive compounds oxidize at a certain potential and thereby liberate electrons that create measurable current. Catecholamines readily form quinones under these conditions, get oxidized, release two electrons, and create current. The electrochemical detector detects this electrical current that linearly correlates to the catecholamine concentration loaded into the ultra-performance liquid chromatography instrument. A 15-min mixing time during the adsorption and desorption steps was found to be optimal. If the washing step was omitted, the catecholamines could not be eluted from the acid-washed alumina. To prevent dilution, the alumina had to be centrifuged and not aspirated to dryness after the washing step. We report here that by changing the range in the electrochemical detector, plasma catecholamines were measured with only 12.5 μL of plasma and more reliably with 25 μL of plasma. The detection limit was 1 ng/mL. This assay method is very useful as blood can be collected from the tail vein in a conscious mouse and the same mouse can be used for time-dependent or age-dependent studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rozet E, Morello R, Lecomte F et al (2006) Performances of a multidimensional on-line SPE-LC-ECD method for the determination of three major catecholamines in native human urine: validation, risk and uncertainty assessments. J Chromatogr B Analyt Technol Biomed Life Sci 844:251–260
Kagedal B, Goldstein DS (1988) Catecholamines and their metabolites. J Chromatogr 429:177–233
Watson E (1981) Liquid chromatography with electrochemical detection for plasma norepinephrine and epinephrine. Life Sci 28:493–497
Keller R, Oke A, Mefford I, Adams RN (1976) Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sci 19:995–1003
Anton AH, Sayre DF (1962) A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138:360–375
Laverty R, Taylor KM (1968) The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal Biochem 22:269–279
Yui Y, Fujita T, Yamamoto T, Itokawa Y, Kawai C (1980) Liquid-chromatographic determination of norepinephrine and epinephrine in human plasma. Clin Chem 26:194–196
Imai K, Wang MT, Yoshiue S, Tamura Z (1973) Determination of catecholamines in the plasma of patients with essential hypertension and of normal persons. Clin Chim Acta 43:145–149
Wang MT, Imai K, Yoshioka M, Tamura Z (1975) Gas-liquid chromatographic and mass fragmentographic determination of catecholamines in human plasma. Clin Chim Acta 63:13–19
Jacob K, Vogt W, Knedel M, Schwertfeger G (1978) Quantitation of adrenaline and noradrenaline from human plasma by combined gas chromatography–high-resolution mass fragmentography. J Chromatogr 146:221–226
Passon PG, Peuler JD (1973) A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem 51:618–631
Weise VK, Kopin IJ (1976) Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure. Life Sci 19:1673–1685
Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19(8):1161–1174
Lucot JB, Jackson N, Bernatova I, Morris M (2005) Measurement of plasma catecholamines in small samples from mice. J Pharmacol Toxicol Methods 52:274–277
Gayen JR, Gu Y, O’Connor DT, Mahata SK (2009) Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin A null mouse. Endocrinology 150:5027–5035
Ying W, Tang K, Avolio E et al (2021) Immunosuppression of macrophages underlies the cardioprotective effects of CST (Catestatin). Hypertension 77:1670–1682
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tang, K., Mahata, S.K. (2023). Determination of Catecholamines in a Small Volume (25 μL) of Plasma from Conscious Mouse Tail Vein. In: Borges, R. (eds) Chromaffin Cells. Methods in Molecular Biology, vol 2565. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2671-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2671-9_22
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2670-2
Online ISBN: 978-1-0716-2671-9
eBook Packages: Springer Protocols